Post-Doc position in the lab of Josh Brody 

The Lymphoma Immunotherapy Program focuses on developing mechanistically novel cancer treatments from animal models through early-phase clinical trials in lymphoid malignancies and solid-tumors.  A priority Project for the available position is following up studies which will be published in April 2019 (Hammerich L et al., Nature Medicine, 2019 in press).

The opportunity will take advantage of unique resources available at the Mount Sinai School of Medicine and Tisch Cancer Institute including access to cutting edge technology developed in the U24-funded Immune Monitoring Core and collaboration with adjoining labs of my colleagues:

-Nina Bhardwaj    Miriam Merad   Brian Brown   Sacha Gnjatic   Benjamin Greenbaum